Details for Patent: 9,593,333
✉ Email this page to a colleague
Which drugs does patent 9,593,333 protect, and when does it expire?
Patent 9,593,333 protects TRYNGOLZA (AUTOINJECTOR) and is included in one NDA.
This patent has thirty-three patent family members in sixteen countries.
Summary for Patent: 9,593,333
| Title: | Modulation of apolipoprotein C-III (ApoCIII) expression in lipoprotein lipase deficient (LPLD) populations |
| Abstract: | Provided are methods, compounds, and compositions for reducing expression of ApoCIII mRNA and protein for treating, preventing, delaying, or ameliorating Fredrickson Type I dyslipidemia/FCS/LPLD, in a patient. Such methods, compounds, and compositions increase HDL levels and/or improving the ratio of TG to HDL and reducing plasma lipids and plasma glucose in the patient, and are useful to treat, prevent, delay, or ameliorate any one or more of pancreatitis, cardiovascular disease, metabolic disorder, and associated symptoms. |
| Inventor(s): | Veronica J. Alexander, Nicholas J. Viney, Joseph L. Witztum |
| Assignee: | Ionis Pharmaceuticals Inc |
| Application Number: | US14/768,180 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,593,333 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; |
Drugs Protected by US Patent 9,593,333
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ionis Pharms Inc | TRYNGOLZA (AUTOINJECTOR) | olezarsen sodium | SOLUTION;SUBCUTANEOUS | 218614-001 | Dec 19, 2024 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | USE IN REDUCING TRIGLYCERIDES IN ADULTS WITH FAMILIAL CHYLOMICRONEMIA SYNDROME (FCS) | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,593,333
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2014216137 | ⤷ Start Trial | |||
| Australia | 2018211325 | ⤷ Start Trial | |||
| Australia | 2020202300 | ⤷ Start Trial | |||
| Brazil | 112015019515 | ⤷ Start Trial | |||
| Canada | 2901119 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
